|
|
|
Home > Business > Reuters > Report
Reddy's files with US FDA for generic Olanzapine
March 11, 2003 11:50 IST
Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the United States, the Bombay Stock Exchange said on Tuesday. It quoted a statement from the company the abbreviated new drug application for the tablets equivalent to the 5 mg, 10 mg, 15 mg and 20 mg forms of the drug was filed under the Para IV certification. This means that if successful, Dr Reddy's can enjoy a 180-day exclusivity for marketing the drug.
© Copyright 2003 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
|
|
|
| Article Tools | | |
| Related Stories | | |
|